Low Dose Growth Hormone (GH) on Insulin Sensitivity and Cortisol Production Rates
- Conditions
- Growth Hormone Deficiency
- Interventions
- Drug: Growth hormone (Genotropin)Drug: Placebo
- First Posted Date
- 2007-08-16
- Last Posted Date
- 2012-05-03
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 16
- Registration Number
- NCT00517062
- Locations
- đēđ¸
Oregon Health and Science University, Portland, Oregon, United States
Ursodiol in Huntington's Disease
- First Posted Date
- 2007-08-10
- Last Posted Date
- 2009-02-05
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 21
- Registration Number
- NCT00514774
- Locations
- đēđ¸
Oregon Health & Science University, Portland, Oregon, United States
A Study of Continuous Oral Contraceptives and Doxycycline
- Conditions
- Contraceptives, Oral
- Interventions
- Drug: placebo dailyDrug: LybrelDrug: Placebo
- First Posted Date
- 2007-05-31
- Last Posted Date
- 2014-10-22
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 131
- Registration Number
- NCT00480532
- Locations
- đēđ¸
University of Hawaii (UH), Honolulu, Hawaii, United States
đēđ¸Oregon Health & Science University, Portland, Oregon, United States
Low Dose Apomorphine and Parkinsonism
- Conditions
- Parkinson's Disease
- First Posted Date
- 2007-05-11
- Last Posted Date
- 2018-11-29
- Lead Sponsor
- Oregon Health and Science University
- Registration Number
- NCT00472355
- Locations
- đēđ¸
Department of Neurology, Oregon Health and Science University, Mail Code OP32, 3181 SW Sam Jackson Park Road, Portland, Oregon, United States
A Study of Genetic and Environmental Factors and Their Effect on Response to Treatment With Lucentis (Ranibizumab) for Wet AMD
- Conditions
- Macular Degeneration
- First Posted Date
- 2007-05-04
- Last Posted Date
- 2011-07-22
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 150
- Registration Number
- NCT00469352
- Locations
- đēđ¸
Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, United States
Rituximab in the Treatment of Scleritis and Non-Infectious Orbital Inflammation
- First Posted Date
- 2006-12-25
- Last Posted Date
- 2013-08-16
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 20
- Registration Number
- NCT00415506
- Locations
- đēđ¸
Oregon Health & Science University, Portland, Oregon, United States
Lucentis (Ranibizumab) for Eales' Disease
- First Posted Date
- 2006-10-06
- Last Posted Date
- 2019-06-11
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 1
- Registration Number
- NCT00384449
- Locations
- đēđ¸
Casey Eye Institute, Portland, Oregon, United States
Prophylactic Therapy for Cytomegalovirus in Liver Transplant Recipients
- Conditions
- Liver Transplantation
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2006-08-17
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 200
- Registration Number
- NCT00364052
Methylphenidate and Parkinson's Disease
- First Posted Date
- 2006-08-02
- Last Posted Date
- 2018-11-29
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 13
- Registration Number
- NCT00359723
- Locations
- đēđ¸
Department of Neurology, OP-2, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, Oregon, United States
Trial of Memantine for Cognitive Impairment in Multiple Sclerosis
- Conditions
- Multiple SclerosisCognition Disorders
- First Posted Date
- 2006-03-09
- Last Posted Date
- 2019-10-15
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 82
- Registration Number
- NCT00300716
- Locations
- đēđ¸
OHSU, Portland, Oregon, United States
đēđ¸USC, Los Angeles, California, United States
đēđ¸MS Hub, Seattle, Washington, United States